A micropeptide molecule that reverses structural and functional changes in the heart could be a promising target for gene therapy.
Researchers have discovered a micropeptide molecule that can restore normal heart function in mice, according to a study in eLife.
The micropeptide works by preventing calcium dysregulation and remodelling of the heart and could be a promising new gene therapy target to treat heart failure.
Among the many processes that lead to heart failure, the disruption caused by calcium is the most prominent. The movement of calcium in and out of cells – known as calcium cycling – is the vital process that allows the heart muscle to contract and relax, pumping blood around the body. Relaxation is controlled by a calcium pump called SERCA, but the action of this molecule is impaired in heart failure and it has previously been suggested that boosting the activity of SERCA could preserve heart contractility and treat heart failure.
“Our lab recently discovered a micropeptide called Dwarf Open Reading Frame (DWORF), which binds directly to SERCA and enhances its activity,” explains lead author Catherine Makarewich, postdoctoral researcher at the University of Texas Southwestern Medical Center, US. “In this study, we explored the therapeutic potential of high levels of DWORF, as a way to increase SERCA activity and improve heart contractility in heart failure.”
The team’s previous work suggested that DWORF works by displacing a molecule that inhibits SERCA, called phospholamban (PLN). To investigate this further, they engineered mice to have higher levels of DWORF and/or PLN in the heart and then studied the effects.
They found that the engineered mice and normal mice had similar cardiac function and structure, but the mice engineered to have higher levels of DWORF showed enhanced calcium cycling. Conversely, heart muscle cells from the mice with higher levels of PLN showed the opposite and had reduced contractility. In the mice engineered to have high levels of both DWORF and PLN, the adverse effects of excess PLN were completely prevented, suggesting that DWORF could protect against its pathological activity.
To investigate this further, the team looked at the effects of increasing the levels of DWORF in mice with dilated cardiomyopathy – a condition in which the heart becomes large and cannot pump properly. When studied by echocardiography, the mice with cardiomyopathy had reduced contraction power in the left ventricle of the heart as shown by a lower ejection fraction (the amount of blood ejected from the heart chamber with each contraction). By contrast, the mice with higher levels of DWORF had significantly improved left ventricular function. Mice that had DWORF removed entirely had even more of a decline in heat function than the normal mice with cardiomyopathy.
High levels of DWORF also prevented the physical hallmarks of cardiomyopathy in the mice – the enlargement of heart chambers, thinning of the chamber wall, and increase in the volume of heart muscle cells. The build-up of scar tissue in the heart is also characteristic of myopathy, and this was also prevented in the mice with elevated levels of DWORF. Taken together, the results show that DWORF can prevent both the functional and structural effects of cardiomyopathy in mice.
“Previous attempts to restore SERCA to protect against heart failure have been unsuccessful because they have focused on increasing levels of SERCA itself,” explains senior author Eric Olson, Professor in Stem Cell Research at UT Southwestern Medical Center. “We believe that increasing levels of DWORF instead may be more feasible, and that the small size of the DWORF molecule could make it an attractive candidate for a gene therapy drug for heart failure.”
Learn more: Micropeptide restores heart function in mice
The Latest on: Micropeptide molecule
[google_news title=”” keyword=”micropeptide molecule” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Micropeptide molecule
- New candidate molecule could become an effective non-hormonal male contraceptiveon January 29, 2023 at 3:59 pm
But now, researchers publishing in ACS' Journal of Medicinal Chemistry have identified a new candidate molecule that could become an effective non-hormonal contraceptive for many people who ...
- A Media Molecule Artist Is Making Stunning Dreams Recreations of The Last of Us Sceneson January 29, 2023 at 8:31 am
As a result, many viewers are diving more into the zombie-like franchise, including the Media Molecule artist Martin Nebelong. In a recent Twitter post, Nebelong showcases a re-imagination of ...
- Monogamous Rodents Don’t Need “Love Molecule” To Pair Upon January 27, 2023 at 8:13 am
Decades of research on the monogamous rodents have led to a better understanding of the so-called love molecule oxytocin, a hormone that studies have suggested is crucial for forming social bonds in ...
- Fight Parkinson’s Disease With New Ocean-Based Moleculeon January 24, 2023 at 11:35 am
Organic chemists have created the first synthetic version of a molecule recently discovered in a sea sponge that may have therapeutic benefits for Parkinson's disease and similar disorders.
- DNA sequencing method detects where and how small molecule drugs interact with the targeted genomeon January 23, 2023 at 10:49 am
In a paper published in the journal Nature Biotechnology, University of Cambridge researchers have outlined a new DNA sequencing method which can detect where and how small molecule drugs interact ...
- Chemists synthesize ocean-based molecule that could fight Parkinson'son January 20, 2023 at 9:19 pm
The problem? Many chemical processes tend to produce not only a version of the molecule found in nature but also a mirror-image version of the molecule that is potentially useless -- or even ...
- In a first, chemists synthesize ocean-based molecule that could fight Parkinson'son January 19, 2023 at 4:00 pm
Organic chemists at UCLA have created the first synthetic version of a molecule recently discovered in a sea sponge that may have therapeutic benefits for Parkinson's disease and similar disorders.
- Small Molecule Targeted Cancer Therapy Market to Hit US$ 225.45 million by 2030 | Accelerating CAGR of 6.40%, Growth Plus Reportson January 19, 2023 at 6:35 am
Newark, New Castle, USA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global small molecule targeted cancer therapy market is expected to ...
- Neuroscientists identify a small molecule that restores visual function after optic nerve injuryon January 19, 2023 at 5:44 am
A research team led by Dr. Ma identified a therapeutic small molecule, M1, which can increase the fusion and motility of mitochondria, resulting in sustained, long-distance axon regeneration.
via Bing News